December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

60.62 -0.73 (-1.18%)
Streaming Delayed Price Updated: 2:37 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 761,277
Open 61.50
Bid (Size) 60.61 (200)
Ask (Size) 60.64 (100)
Prev. Close 61.35
Today's Range 60.30 - 61.50
52wk Range 49.26 - 70.98
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone ↗
BioMarin Pharmaceutical (NASDAQ:BMRN) said it is progressing with the integration of Amicus Therapeutics while pursuing additional business-development opportunities, as executives outlined growth... 
Via MarketBeat
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory

Performance

YTD
+2.0%
+2.0%
1 Month
-8.3%
-8.3%
3 Month
+5.7%
+5.7%
6 Month
+9.1%
+9.1%
1 Year
+12.7%
+12.7%

More News

Read More
BioMarin Pharmaceutical (NASDAQ:BMRN) Forms Tight Breakout Setup With Strong Technicals ↗
Via Chartmill
News headline image
3 Reasons to Avoid BMRN and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
3 Value Stocks We Think Twice About
Via StockStory
BioMarin (NASDAQ:BMRN) Stands Out as an Undervalued Stock with Solid Fundamentals ↗
Via Chartmill
BioMarin Pharmaceutical (NASDAQ:BMRN): A Value Stock with Strong Fundamentals ↗
Via Chartmill
BioMarin Pharmaceutical (NASDAQ:BMRN) Presents a High-Quality Breakout Setup with Strong Technical Ratings ↗
Via Chartmill
News headline image
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Via StockStory
News headline image
3 Cash-Producing Stocks We Find Risky
Via StockStory
News headline image
BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth ↗
Via MarketBeat
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Shows Strong Value Potential with a 7/10 Overall Rating ↗
Via Chartmill
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Decent Value Play with Strong Fundamentals ↗
Via Chartmill
News headline image
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
Via StockStory
News headline image
BioMarin Pharmaceutical Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory
News headline image
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down
Via StockStory
News headline image
2 Reasons to Avoid BMRN and 1 Stock to Buy Instead
Via StockStory
Topics Artificial Intelligence
News headline image
1 of Wall Street’s Favorite Stocks with Competitive Advantages and 2 We Avoid
Via StockStory
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Via StockStory
News headline image
Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest
Via StockStory
Topics Artificial Intelligence
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 60.62
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 09/25/26 02:37 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 11.12B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.